Modified Citrus Pectin
Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer
New Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer
Ovarian cancer is one of the deadliest cancers because it’s often detected at a late stage, with higher risk of resistance to frontline chemotherapy drugs such as paclitaxel (commonly sold as Taxol). However, a new preclinical study from the University of Tehran and the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, published in the Asian Pacific Journal of Cancer Prevention showed that Modified Citrus Pectin (MCP) increased the effectiveness of paclitaxel against ovarian cancer cells.
By Dr. Eliaz Staff
February 7, 2019
